Doppler Ultrasound Applications in Liver Disease Management

Doppler ultrasound has emerged as a cornerstone in the non-invasive assessment and management of liver disease by providing real-time information on vascular flow, resistance and tissue perfusion. Its capacity to quantify parameters such as peak flow velocity, resistive index and pulsatility index enables clinicians to detect portal hypertension, characterise fibrosis and monitor haemodynamic changes during cirrhosis progression. Coupling Doppler measurements with elastography techniques enhances diagnostic accuracy, allowing discrimination between mild and advanced fibrosis without the need for biopsy. In transplant evaluation, Doppler assessment of hepatic artery and portal vein flow patterns aids in early identification of vascular complications. Beyond diagnostics, serial Doppler studies guide therapeutic decision-making by tracking response to antiviral or antifibrotic treatments. Recent advances in automated flow quantification and machine-learning-driven feature extraction promise to standardise assessment protocols and extend applications into telemedicine and point-of-care settings. These developments underscore the global significance of Doppler ultrasound as a versatile, cost-effective tool in liver disease management.

Research from Nature Portfolio

Recent studies have demonstrated the value of portal vein Doppler metrics in predicting liver fibrosis. One investigation compared right portal vein peak velocity with liver stiffness measurements obtained via transient and shear-wave elastography in patients with chronic liver disease. A strong inverse relationship was observed between portal vein peak velocity and stiffness values, and a threshold velocity below 17 cm/s distinguished significant fibrosis with comparable accuracy to established serological indices. Another foundational study explored multiparametric ultrasound analyses by extracting quantitative features of echogenicity and heterogeneity. Although focused on B-mode imaging, the study highlighted the potential for integrating Doppler-derived flow patterns into radiomics workflows, enabling logistic models to differentiate clinically relevant fibrosis stages. Together, these works illustrate the trend towards combining haemodynamic parameters with advanced image analytics to refine non-invasive staging of liver disease.

Doppler Ultrasound Applications in Liver Disease Management publication trend

The graph below shows the total number of articles in doppler ultrasound applications in liver disease management across all publications each year (not limited to Nature Index journals).

Technical terms

Doppler ultrasonography: An imaging method that assesses blood flow velocities by measuring frequency shifts of reflected ultrasound waves.

Peak flow velocity: The maximum speed of blood flow within a vessel during the cardiac cycle.

Pulsatility index: A ratio quantifying the variation between peak systolic and end-diastolic velocities, reflecting downstream resistance.

Resistive index: A measure of vascular resistance calculated as (peak systolic velocity – end-diastolic velocity) divided by peak systolic velocity.

Radiomics: The process of extracting large sets of quantitative features from medical images for statistical analysis and predictive modelling.

References

1. Comparison of portal vein hemodynamics with ultrasound-based elastography for the prediction of liver fibrosis in patients with chronic liver disease. Scientific Reports (2023).
2. The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver Disease. Diagnostics (2024).
3. B-mode ultrasound for the assessment of hepatic fibrosis: a quantitative multiparametric analysis for a radiomics approach. Scientific Reports (2019).
4. Altered Doppler flow patterns in cirrhosis patients: an overview. Ultrasonography (2015).
5. Doppler ultrasound in liver cirrhosis: correlation of hepatic artery and portal vein measurements with model for end-stage liver disease score in Egypt. Egyptian Journal of Radiology and Nuclear Medicine (2020).